SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) ('Scienture”) a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and ...

This article argues for the adoption of a combined lyophilized plasma and platelet product strategy to address critical gaps.

Speed to market wont guarantee success in todays launch environment. Anticipating what prescribers, patients and payers will ...

Overcoming common challenges with today’s biologics, such as developing devices for high-concentration subcutaneous ...

SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) ("Scienture") a holding company for existing and planned pharmaceutical operating companies focused on providing ...

Homegrown premium sleep solutions brand Getha has unveiled its latest flagship product, the evolved and improved Transforme ...

From a chemistry, manufacturing, and controls (CMC) perspective, ADCs present unique hurdles. “ADCs introduce unique challenges across areas like process and purification development, analytical ...

Suppliers are supporting railroads—and track—with crossties that not only maintain track gauge but also remain in service ...

For most of the solar industry’s modern history, progress has been framed as a story of physics. Higher efficiencies came ...

As the rapid expansion of biologics continues, today’s high‑concentration injectables, prefilled syringes and cartridges, as ...

Mars is working on a vegan ice cream that resists melting for hours—but is that innovation what consumers actually want?